Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Sullivan

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Epilepsy & Behavior : E&B|December 4, 2022
Fenfluramine treatment is associated with improvement in everyday executive function in preschool-aged children (<5 years) with Dravet syndrome: A critical period for early neurodevelopmentKim I Bishop, Peter K Isquith, Gerard A Gioia, et al.
Neurology|November 14, 2025
Natural History of Children and Adolescents With Dravet Syndrome: A 24-Month Follow-UpJoseph Sullivan, Elaine C Wirrell, Kelly G Knupp, et al.
Epilepsia|March 12, 2025
Long-term safety and effectiveness of fenfluramine in children and adults with Dravet syndromeIngrid E Scheffer, Rima Nabbout, Lieven Lagae, et al.
Pediatrics|September 3, 2014
Cardio-facio-cutaneous syndrome: clinical features, diagnosis, and management guidelinesMary Ella M Pierpont, Pilar L Magoulas, Saleh Adi, et al.
Epilepsy & Behavior : E&B|August 5, 2021
Treatment with fenfluramine in patients with Dravet syndrome has no long-term effects on weight and growthAntonio Gil-Nagel, Joseph Sullivan, Berten Ceulemans, et al.
Epilepsia|July 16, 2013
Stiripentol in Dravet syndrome: results of a retrospective U.S. studyElaine C Wirrell, Linda Laux, David N Franz, et al.
The New England Journal of Medicine|March 4, 2026
Zorevunersen in Children and Adolescents with Dravet SyndromeLinda Laux, Joseph Sullivan, M Scott Perry, et al.
Epilepsia Open|August 24, 2019
Possible precision medicine implications from genetic testing using combined detection of sequence and intragenic copy number variants in a large cohort with childhood epilepsyRebecca Truty, Nila Patil, Raman Sankar, et al.
Epilepsia|August 6, 2023
Fenfluramine in the treatment of Dravet syndrome: Results of a third randomized, placebo-controlled clinical trialJoseph Sullivan, Lieven Lagae, J Helen Cross, et al.
Lancet (London, England)|December 22, 2019
Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trialLieven Lagae, Joseph Sullivan, Kelly Knupp, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Epilepsy & Behavior : E&B|December 4, 2022
Fenfluramine treatment is associated with improvement in everyday executive function in preschool-aged children (<5 years) with Dravet syndrome: A critical period for early neurodevelopmentKim I Bishop, Peter K Isquith, Gerard A Gioia, et al.
Neurology|November 14, 2025
Natural History of Children and Adolescents With Dravet Syndrome: A 24-Month Follow-UpJoseph Sullivan, Elaine C Wirrell, Kelly G Knupp, et al.
Epilepsia|March 12, 2025
Long-term safety and effectiveness of fenfluramine in children and adults with Dravet syndromeIngrid E Scheffer, Rima Nabbout, Lieven Lagae, et al.
Pediatrics|September 3, 2014
Cardio-facio-cutaneous syndrome: clinical features, diagnosis, and management guidelinesMary Ella M Pierpont, Pilar L Magoulas, Saleh Adi, et al.
Epilepsy & Behavior : E&B|August 5, 2021
Treatment with fenfluramine in patients with Dravet syndrome has no long-term effects on weight and growthAntonio Gil-Nagel, Joseph Sullivan, Berten Ceulemans, et al.
Epilepsia|July 16, 2013
Stiripentol in Dravet syndrome: results of a retrospective U.S. studyElaine C Wirrell, Linda Laux, David N Franz, et al.
The New England Journal of Medicine|March 4, 2026
Zorevunersen in Children and Adolescents with Dravet SyndromeLinda Laux, Joseph Sullivan, M Scott Perry, et al.
Epilepsia Open|August 24, 2019
Possible precision medicine implications from genetic testing using combined detection of sequence and intragenic copy number variants in a large cohort with childhood epilepsyRebecca Truty, Nila Patil, Raman Sankar, et al.
Epilepsia|August 6, 2023
Fenfluramine in the treatment of Dravet syndrome: Results of a third randomized, placebo-controlled clinical trialJoseph Sullivan, Lieven Lagae, J Helen Cross, et al.
Lancet (London, England)|December 22, 2019
Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trialLieven Lagae, Joseph Sullivan, Kelly Knupp, et al.
Pageof 10